Intravascular large B-cell lymphoma: successful therapy with bendamustine and rituximab.
Mleczko
Anna
A
Department of Dermatology and Venereology, Otto-von-Guericke University Magdeburg Leipziger Str. 44, DE-39120 Magdeburg, Germany.
Franke
Ingolf
I
Scheinpflug
Karin
K
Gollnick
Harald
H
Leverkus
Martin
M
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D001808:Blood Vessels / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000473:pathology; D016393:Lymphoma, B-Cell; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction; D000069283:Rituximab; D012878:Skin Neoplasms / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D000069283:Rituximab; D000069461:Bendamustine Hydrochloride